- Analysis of surgeries performed after hysteroscopic sterilization as tabulated from 3,803 Essure patient experiences
-
Sills ES, Li X, Wood SH, Jones CA
- KMID: 2378592
- Obstet Gynecol Sci.
- 2017 May;60(3):296-302.
- doi: 10.5468/ogs.2017.60.3.296
OBJECTIVE: Although previous research has suggested that risk for reoperation among hysteroscopic sterilization (HS) patients is more than ten times higher than for patients undergoing standard laparoscopic tubal ligation, little... -
- CITED
-
- Close
- SHARE
-
- Close
- Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management
-
Sills ES, Walsh DJ, Jones CA, Wood SH
- KMID: 2069038
- Clin Exp Reprod Med.
- 2015 Sep;42(3):126-129.
- doi: 10.5653/cerm.2015.42.3.126
Essure (Bayer) received approval from the U.S. Food and Drugs Administration as a permanent non-hormonal contraceptive implant in November 2002. While the use of Essure in the management of hydrosalpinx... -
- CITED
-
- Close
- SHARE
-
- Close
- Contraceptive failure after hysteroscopic sterilization: Analysis of clinical and demographic data from 103 unplanned pregnancies
-
Sills ES, Li X, Jones CA, Wood SH
- KMID: 2314065
- Obstet Gynecol Sci.
- 2015 Nov;58(6):487-493.
- doi: 10.5468/ogs.2015.58.6.487
OBJECTIVE: This investigation examined data on unplanned pregnancies following hysteroscopic sterilization (HS). METHODS: A confidential questionnaire was used to collect data from women with medically confirmed pregnancy (n=103) registered after undergoing... -
- CITED
-
- Close
- SHARE
-
- Close
